Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Parkinsonism: onset, progression, and mortality. 1967.

Hoehn MM, Yahr MD.

Neurology. 2001 Nov;57(10 Suppl 3):S11-26. No abstract available.

PMID:
11775596
2.

Falling asleep at the wheel: motor vehicle mishaps in people taking pramipexole and ropinirole.

Hoehn MM.

Neurology. 2000 Jan 11;54(1):275; author reply 276-7. No abstract available.

PMID:
10636181
3.

Parkinsonism: onset, progression, and mortality. 1967.

Hoehn MM, Yahr MD.

Neurology. 1998 Feb;50(2):318 and 16 pages following. No abstract available.

PMID:
9484345
4.
5.

An examination of male-female differences in progression and mortality of Parkinson's disease.

Diamond SG, Markham CH, Hoehn MM, McDowell FH, Muenter MD.

Neurology. 1990 May;40(5):763-6.

PMID:
2330103
6.

Effect of age at onset on progression and mortality in Parkinson's disease.

Diamond SG, Markham CH, Hoehn MM, McDowell FH, Muenter MD.

Neurology. 1989 Sep;39(9):1187-90.

PMID:
2771070
7.

Multi-center study of Parkinson mortality with early versus later dopa treatment.

Diamond SG, Markham CH, Hoehn MM, McDowell FH, Muenter MD.

Ann Neurol. 1987 Jul;22(1):8-12.

PMID:
3631925
8.

Parkinson's disease: progression and mortality.

Hoehn MM.

Adv Neurol. 1987;45:457-61.

PMID:
3825726
9.
10.

Low dosages of bromocriptine added to levodopa in Parkinson's disease.

Hoehn MM, Elton RL.

Neurology. 1985 Feb;35(2):199-206.

PMID:
3969207
11.

A51568A: N-demethylvancomycin.

Hunt AH, Marconi GG, Elzey TK, Hoehn MM.

J Antibiot (Tokyo). 1984 Aug;37(8):917-9. No abstract available.

12.

The discovery, fermentation, isolation, and structure of antibiotic A33853 and its tetraacetyl derivative.

Michel KH, Boeck LD, Hoehn MM, Jones ND, Chaney MO.

J Antibiot (Tokyo). 1984 May;37(5):441-5.

13.

Bromocriptine and its use in Parkinsonism.

Hoehn MM.

J Am Geriatr Soc. 1981 Jun;29(6):251-8.

PMID:
7240612
14.

Chronic levodopa and renal function.

Hoehn MM.

Can J Neurol Sci. 1981 May;8(2):139-42.

PMID:
7296422
16.

Neuropsychological impairment with schizophrenia vs. acute and chronic cerebral lesions.

Heaton RK, Vogt AT, Hoehn MM, Lewis JA, Crowley TJ, Stallings MA.

J Clin Psychol. 1979 Jan;35(1):46-53.

PMID:
422730
17.

Hypothalamic atrophy.

Kelts KA, Hoehn MM.

J Clin Psychiatry. 1978 Apr;39(4):357-8, 363-5.

PMID:
580284
18.

Dopamine excretion and vulnerability to drug-induced Parkinsonism. Schizophrenic patients.

Crowley TJ, Hoehn MM, Rutledge CO, Stallings MA, Heaton RK, Sundell S, Stilson D.

Arch Gen Psychiatry. 1978 Jan;35(1):97-104.

PMID:
619844
19.

A32390A, a new biologically active metabolite. I. Discovery and fermentation studies.

Boeck LD, Hoehn MM, Sands TH, Wetzel RW.

J Antibiot (Tokyo). 1978 Jan;31(1):19-26.

20.

Spinal myoclonus.

Hoehn MM, Cherington M.

Neurology. 1977 Oct;27(10):942-6.

PMID:
561907
21.

Effects of levodopa on the renin-aldosterone system.

Katz FH, Hoehn MM.

Clin Pharmacol Ther. 1977 Apr;21(4):388-91.

PMID:
321175
22.

The Parkinsonian syndrome and its dopamine correlates.

Hoehn MM, Crowley TJ, Rutledge CO.

Adv Exp Med Biol. 1977;90:243-54.

PMID:
930745
23.

Dopamine correlates of neurological and psychological status in untreated Parkinsonism.

Hoehn MM, Crowley TJ, Rutledge CO.

J Neurol Neurosurg Psychiatry. 1976 Oct;39(10):941-51.

24.

A trial of antilymphocyte globulin in the treatment of chronic progressive multiple sclerosis.

Walker JE, Hoehn MM, Kashiwagi N.

J Neurol Sci. 1976 Oct;29(2-4):303-9.

PMID:
978212
25.

Low urinary dopamine and prediction of phenothiazine-induced Parkinsonism: a preliminary report.

Crowley TJ, Rutledge CO, Hoehn MM, Stallings MA, Sundell S.

Am J Psychiatry. 1976 Jun;133(6):703-6.

PMID:
1275103
26.

A30641, a new epidithiodiketopiperazine with antifungal activity.

Berg DH, Massing RP, Hoehn MM, Boeck LD, Hamill RL.

J Antibiot (Tokyo). 1976 Apr;29(4):394-7.

27.

Age distribution of patients with Parkinsonism.

Hoehn MM.

J Am Geriatr Soc. 1976 Feb;24(2):79-85.

PMID:
765387
28.

The separation and identification of dopamine 3-O-sulfate and dopamine 4-O-sulfate in urine of Parkinsonian patients.

Bronaugh RL, Hattox SE, Hoehn MM, Murphy RC, Rutledge CO.

J Pharmacol Exp Ther. 1975 Dec;195(3):441-52.

PMID:
1195131
29.

Acute overdose with levodopa. Clinical and biochemical consequences.

Hoehn MM, Rutledge CO.

Neurology. 1975 Aug;25(8):792-4.

PMID:
1171416
30.

Conjugation of L-DOPA and its metabolites after oral and intravenous administration to Parkinsonian patients.

Bronaugh RL, MacMurtry RJ, Hoehn MM, Rutledge CO.

Biochem Pharmacol. 1975 Jul 15;24(13-14):1317-20. No abstract available.

PMID:
1096899
31.

Structure of althiomycin.

Kirst HA, Szymanski EF, Dorman DE, Occolowitz JL, Jones ND, Chaney MO, Hamill RL, Hoehn MM.

J Antibiot (Tokyo). 1975 Apr;28(4):286-91. No abstract available.

32.

New azasteroidal antifungal antibotics from Geotrichum flavo-brunneum. I. Discovery and fermentation studies.

Boeck LD, Hoehn MM, Westhead JE, Wolter RK, Thomas DN.

J Antibiot (Tokyo). 1975 Feb;28(2):95-101.

33.
34.

The antibiotic activity of cultures from fungal spores collected by a spore trap on permanent pasture.

Brewer D, Taylor A, Hoehn MM.

Can J Microbiol. 1974 May;20(5):721-9. No abstract available.

PMID:
4857622
35.

Letter: The occurrence of deacetoxycephalosporin C in fungi and streptomycetes.

Higgens CE, Hamill RL, Sands TH, Hoehn MM, Davis NE.

J Antibiot (Tokyo). 1974 Apr;27(4):298-300. No abstract available.

36.

Epipolythiopiperazinedione antibiotics from Penicillium turbatum.

Michel KH, Chaney MO, Jones ND, Hoehn MM, Nagarajan R.

J Antibiot (Tokyo). 1974 Jan;27(1):57-64. No abstract available.

37.

Sulphate conjugation and L-dopa treatment of Parkinsonian patients.

Rutledge CO, Hoehn MM.

Nature. 1973 Aug 17;244(5416):447-50. No abstract available.

PMID:
4582501
38.

A9145, a new adenine-containing antifungal antibiotic. I. Discovery and isolation.

Hamil RL, Hoehn MM.

J Antibiot (Tokyo). 1973 Aug;26(8):463-5. No abstract available.

39.

Parkinsonism: alterations in spatial orientation as determined by a route-walking test.

Bowen FP, Hoehn MM, Yahr MD.

Neuropsychologia. 1972 Sep;10(3):355-61. No abstract available.

PMID:
5080496
40.

Cerebral dominance in relation to tracking and tapping performance in patients with parkinsonism.

Bowen FP, Hoehn MM, Yahr MD.

Neurology. 1972 Jan;22(1):32-9. No abstract available.

PMID:
5061837
41.

Beta-lactam antibiotics from Streptomyces.

Nagarajan R, Boeck LD, Gorman M, Hamill RL, Higgens CE, Hoehn MM, Stark WM, Whitney JG.

J Am Chem Soc. 1971 May 5;93(9):2308-10. No abstract available.

PMID:
5553073
42.
43.

A study of the behavior of propionyl erythromycin in blood by a new chromatographic method.

Stephens VC, Pugh CT, Davis NE, Hoehn MM, Ralston S.

J Antibiot (Tokyo). 1969 Nov;22(11):551-7. No abstract available.

44.

Treatment of parkinsonism with levodopa.

Yahr MD, Duvoisin RC, Schear MJ, Barrett RE, Hoehn MM.

Arch Neurol. 1969 Oct;21(4):343-54. No abstract available.

PMID:
5820999
45.

Dianemycin, an antibiotic of the group affecting ion transport.

Hamill RL, Hoehn MM, Pittenger GE, Chamberlin J, Gorman M.

J Antibiot (Tokyo). 1969 Apr;22(4):161-4. No abstract available.

46.
47.

L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism.

Yahr MD, Duvoisin RC, Hoehn MM, Schear MJ, Barrett RE.

Trans Am Neurol Assoc. 1968;93:56-63. No abstract available.

PMID:
4885744
48.

Parkinsonism: onset, progression and mortality.

Hoehn MM, Yahr MD.

Neurology. 1967 May;17(5):427-42. No abstract available.

PMID:
6067254
49.

Monensin, a new biologically active compound. I. Discovery and isolation.

Haney ME Jr, Hoehn MM.

Antimicrob Agents Chemother (Bethesda). 1967;7:349-52. No abstract available.

PMID:
5596158
50.

Nebramycin, a new broad-spectrum antibiotic complex. I. Detection and biosynthesis.

Stark WM, Hoehn MM, Knox NG.

Antimicrob Agents Chemother (Bethesda). 1967;7:314-23. No abstract available.

PMID:
5596154

Supplemental Content

Loading ...
Support Center